http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CL-2008002163-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_966a6c1f382ec9bcb5e3839dfd73e5b8
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-22
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-24
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D205-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-30
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D207-09
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-28
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-40
filingDate 2008-07-24-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_774188aff49c48956caa3fc928df00e3
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5f18e20a664ed34e7c6e47f9554405bc
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_99a4b1e8af82095fa212724d60dbd8fc
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4c2381039933d47cd4a805d472b0c268
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_301733a90bfa3319ba3edff5943f7d95
publicationDate 2009-05-22-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CL-2008002163-A1
titleOfInvention Derivatives of 2-azetidine and 2-pyrrolidine methanoamines; its procurement processes; the pharmaceutical composition that they contain; and its uses.
abstract Compounds derived from 2-azetidinemethanoamines, and 2-pyrrolidinemethanoamines; Preparation method; pharmaceutical composition containing them; and use in the preparation of medications for the treatment of depression, anxiety disorders and bipolar disorders, among others.
priorityDate 2007-07-27-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID31268
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419551550

Total number of triples: 34.